Jean-Francois Dufour, MD; Ronald DeLellis, MD; Marshall M. Kaplan, MD
Dufour J., DeLellis R., Kaplan M.; Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis. Ann Intern Med. 1997;127:981-985. doi: 10.7326/0003-4819-127-11-199712010-00006
Download citation file:
Published: Ann Intern Med. 1997;127(11):981-985.
Hepatic fibrosis and cirrhosis occur in many types of chronic liver injury and generally seem to be irreversible.
To determine whether cirrhosis caused by autoimmune hepatitis can be reversible.
Eight patients with autoimmune hepatitis and cirrhosis who responded to medical therapy and had follow-up liver biopsy while in clinical and biochemical remission.
Biopsy specimens were randomly coded in an unpaired manner according to patient and were read independently by two pathologists using the Knodell scoring system.
The median alanine aminotransferase level decreased from 10.30 µkat/L to 0.37 µkat/L, the median serum bilirubin level decreased from 70 µmol/L to 10 µmol/L, and the median serum albumin level increased from 34 g/L to 43 g/L. Cirrhosis, extensive fibrosis, or both were present in all patients at diagnosis but were not present on follow-up liver biopsy. The median Knodell score decreased from 14.0 to 1.3, and the median fibrosis score decreased from 3.3 to 0.8.
Hepatic fibrosis and cirrhosis may be reversible in some patients in whom autoimmune hepatitis responds to treatment.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Gastroenterology/Hepatology, Liver Disease.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only